Бізнес · 18.12.20231 хв читання
Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA or the Agency) is withdrawing approval of two new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.